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Abstract Many receptors coupled to inhibitory Go/Gi-type G
proteins often also produce stimulatory signals like Ca2+
mobilisation. When expressed in CHO cells the K2-adrenoceptor
subtypes K2A, K2B and K2C mobilised Ca2+. These responses
were strongly reduced by the P2Y-purinoceptor antagonist
suramin. A large proportion of the total pool of purine
nucleotides was found extracellularly. Removal of extracellular
nucleotides with apyrase or by constant perfusion had a similar
effect as suramin. These treatments did not affect the K2-
adrenoceptor-mediated inhibition of cAMP production. This
indicates that cells may be primed or their signaling pathways
redirected towards Ca2+ mobilisation by ‘autocrine’ release of
nucleotides.
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1. Introduction
A major group of G protein-coupled receptors transduce
signals through Go/Gi-proteins. These receptors couple to
ion channels and to inhibition of cAMP production, and
are considered mainly inhibitory in their action. However, in
some cells a stimulatory response such as Ca2 elevation is
observed upon activation of this type of receptors [1]. This has
in many studies been observed for K2-adrenoceptors. The K2-
adrenoceptors couple in many cells to production of inositol-
1,4,5-trisphosphate [2^5] and Ca2 mobilisation [3^8] by a
mechanism which is sensitive to inhibitors of phospholipase
C such as U73122 [4,5]. The Ca2 elevation is pertussis toxin-
sensitive [3^8] and hence due to Go/Gi-protein activation. Un-
like Kq, the K subunits of Go/Gi (Ko/Ki) are unable to activate
phospholipase C-L [9,10] but LQ subunits may activate the
enzyme [11^13]. Indeed, evidence for the involvement of LQ
subunits in K2-receptor-mediated Ca2 mobilisation has been
presented [5]. The stimulatory activity of K2-receptors is of
physiological importance for mediation of functions such as
platelet aggregation, secretion and contraction of smooth
muscle [14]. In all these cases, Ca2 elevation is either directly
or indirectly implicated. Other Go/Gi-coupled receptors, such
as opiate receptors, have been able to elevate cytosolic Ca2
only after prior stimulation of Gq-coupled receptors such as
muscarinic receptors [15]. Similarly, activation of Gq-coupled
P2Y-purinoceptors by addition of ATP has been shown to
amplify pertussis toxin-sensitive Ca2 mobilisation through
A1 adenosine [16] and M4 muscarinic receptors [17]. Most
cells express P2Y-purinoceptors which may be activated al-
ready at the physiological extracellular levels of purine nucleo-
tides [18,19]. High extracellular levels of purine nucleotides are
usually a result of exocytotic or anion transporter-mediated
release [18,19]. Endogenously activated P2Y-receptors may
thus enable Go/Gi-coupled receptors to mobilise Ca2.
The aim of this study was to use the fura-2 method [20] to
determine whether released endogenous purine nucleotides
acting on endogenous P2Y-receptors cooperate to enable K2-
adrenoceptors to mobilise intracellular free Ca2.
2. Materials and methods
2.1. Reagents
Apyrase, EGTA (ethylene glycol-bis[L-aminoethyl ether]N,N,NP,
NP-tetraacetic acid), noradrenaline, probenecid (p-[dipropylsulfamoyl]-
benzoic acid) and suramin were purchased from Sigma Chemical Co.
(St. Louis, MO). Digitonin was purchased from Merck AG (Darm-
stadt, Germany) and fura-2 acetoxymethyl ester from Molecular
Probes Inc. (Eugene).
2.2. Cells
CHO (Chinese hamster ovary) cells (American Type Culture Col-
lection, Manossas, VI, USA), transfected as described in [21] were
grown in MEM alpha (Gibco, Paisley, UK) supplemented with
0.22% (w/v) NaHCO3, 100 U/ml penicillin G, 80 U/ml streptomycin
(Sigma) and 5% (v/v) foetal calf serum (Gibco) at 37‡C in 5% CO2 in
an air ventilated humidi¢ed incubator in 260 ml plastic culture £asks
(75 cm2 bottom area; Nunc A/S, Roskilde, Denmark) or in plastic
culture dishes (diameter 94 mm; Greiner GmbH, Frickenhausen, Ger-
many).
2.3. Ca2+ measurements
The £uorescent Ca2 indicator fura-2 [20] was used to monitor
changes in intracellular Ca2. The cells were harvested using phos-
phate bu¡ered saline containing 0.2 g/l ethylenediaminetetraacetic
acid (EDTA), spun down, and loaded at 37‡C in MEM alpha supple-
mented with 0.002% (w/v) bovine serum albumin, 1 mM probenecid
and 4 WM fura-2 acetoxymethyl ester for 20 min. The cells were
washed once with Ca2-free TBM and stored on ice as pellets (me-
dium removed). The measurement of intracellular free calcium was
carried out as follows: one pellet was resuspended in TBM (TES
bu¡ered medium consisting of 137 mM NaCl, 5 mM KCl, 1 mM
CaCl2, 10 mM glucose, 1.2 mM MgCl2, 0.44 mM KH2PO4, 4.2
mM NaHCO3 and 20 mM 2-([2-hydroxy-1,1-bis{hydroxymethyl}-
ethyl]amino) ethane sulphonic acid (TES) adjusted to pH 7.4 with
NaOH) at 37‡C and placed in a stirred quartz microcuvette in a
thermostated cell-holder within a £uorescence spectrophotometer.
Fluorescence was monitored either with a Hitachi F-2000 or a Hitachi
F-4000 £uorescence spectrophotometer at the wavelengths 340 nm
(excitation), 505 nm (emission) or with a PTI QuantaMaster £uores-
cence spectrophotometer at the wavelengths 340/360/380 nm (excita-
tion), 505 nm (emission). Suramin or apyrase were added 4 min prior
to the addition or noradrenaline. The experiments were calibrated
using 60 Wg/ml digitonin, which gives the maximum value of £uores-
cence (Fmax) and 10 mM EGTA, which gives the minimum value of
£uorescence (Fmin). The free Ca2 concentration was calculated from
the £uorescence (F) using the equation:
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Ca2  F3Fmin=Fmax3FU224 nM
in which the extracellular fura-2 £uorescence is subtracted from the F
values.
The Ca2 imaging experiments were performed and the data ana-
lysed using Intracellular Imaging InCyt2 £uorescence imaging system
(Cincinnati, OH, USA). The cells were kept in TBM at 37‡C and
excited by alternating wavelengths of 340 and 380 nm using narrow
band excitation ¢lters and the £uorescence was measured through a
430 nm dichroic mirror and a 510 nm barrier ¢lter with a Cohu CCD
camera. One ratioed image was acquired per second.
2.4. Measurements of extracellular purine nucleotides and cAMP
The CHO cells on petri dishes were incubated with 5 WCi/ml
[3H]adenine in culture medium at 37‡C for 2 h before they were
harvested as above and spun down. The pellet was resuspended in
TBM and divided into aliquots of about 106 cells/0.8 ml. The cells
were preincubated with 0.5 mM IBMX (3-isobutyl-1-methyl-xanthine)
and 150 WM quinacrine for 10 min at 37‡C with or without 2 U/ml
apyrase. After another 10 min incubation with the drugs the cells were
spun down and the supernatants removed. Supernatants from control
and apyrase treated samples were loaded into Dowex columns and
[3H]ATP eluted with 2 ml H2O. The eluted radioactivity was deter-
mined in a liquid scintillation counter. The pellets were resuspended in
1 ml 0.33 M perchloric acid containing about 1500 cpm [14C]cAMP.
Cyclic AMP was isolated by sequential Dowex/alumina ion exchange
chromatography and radioactivity was determined in a liquid scintil-
lation counter [22]. The conversion of [3H]ATP to [3H]cAMP was
calculated as a percentage of total cellular [3H]ATP and normalised
to the recovery of [14C]cAMP.
3. Results
When added to CHO cells expressing K2-adrenoceptors,
ATP (10 WM) caused a rapid slowly declining increase in
intracellular free Ca2 (Fig. 1A). Pretreatment with EGTA
did not a¡ect the magnitude of the response to ATP. In con-
trol conditions the peak v[Ca2]i response to 10 WM ATP was
120 þ 4 nM ( þ S.D., n = 4) and in the presence of 2 mM
EGTA it was 130 þ 8 nM ( þ S.D., n = 4). This suggests that
the Ca2 signals are due to intracellular Ca2 mobilisation
and hence result from P2Y-receptor activation. When measure-
ments were performed in the presence of 2 U/ml apyrase (an
enzyme that hydrolyses adenine nucleotides to adenosine and
phosphate) the response to ATP became more transient indi-
cating that the added ATP was rapidly hydrolyzed (Fig. 1B).
Addition of 100 WM suramin ^ a relatively subtype non-selec-
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Fig. 1. The e¡ect of apyrase on ATP and noradrenaline-mediated
increase in intracellular free Ca2 as determined using fura-2. CHO
cells expressing the K2C subtype were detached from the culture
dishes using EDTA and loaded with fura-2 acetoxymethyl ester (A^
G). Original £uorescence recordings from cell suspensions (about
500 000 cells/ml) are shown. In A, 10 WM ATP was added where in-
dicated. In B and C, 10 WM ATP was added to cells pretreated for
4 min with either 2 U/ml apyrase or 100 WM suramin, respectively.
In D, 10 WM noradrenaline, and in E, 1 mM ATP and 10 WM nor-
adrenaline were added. In F and G, cells were pretreated for 4 min
with apyrase whereafter 10 WM noradrenaline or 1 mM ATP and
10 WM noradrenaline, respectively, were added where indicated.
Fig. 2. E¡ect of apyrase and suramin on ATP and noradrenaline-
mediated increase in intracellular free Ca2. In A, the peak values
for the increase in fura-2 £uorescence from several measurements in
the presence and absence of apyrase, similar to those in Fig. 1D
and F, have been averaged ( þ S.D.), for the di¡erent K2-adrenore-
ceptor subtypes (K2A, n = 12; K2B, n = 16; K2C, n = 24). In B, experi-
ments were performed as in Fig. 1A and C. Cells were pretreated
for 4 min in the absence or in the presence of 200 WM suramin
whereafter 10 WM noradrenaline or 10 WM ATP was added. Each
data point is an average from 6^8 measurements ( þ S.D.). The sig-
ni¢cances are indicated with respect to the untreated controls (***:
Ps 0.001, student’s two-tailed t-test).
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tive P2Y-receptor antagonist ^ signi¢cantly reduced the re-
sponse to ATP (Fig. 1C). The response to 100 nM thapsigar-
gin was una¡ected by suramin (in the absence of suramin the
v[Ca2]i was 36 þ 6 nM, þ S.D., n = 3 and in the presence of
200 WM suramin it was 37 þ 6 nM, þ S.D., n = 4, 5 min after
the addition of thapsigargin) indicating that the e¡ect of sur-
amin is not on Ca2 mobilisation itself. This indicates that the
responses mediated by the endogenous P2Y-receptors in CHO
cells [23] are sensitive to these treatments (apyrase or sura-
min). Addition of noradrenaline (10 WM) to CHO cells ex-
pressing the K2-adrenoceptor subtypes (K2A, K2B, K2C) also
resulted in an increase in intracellular free Ca2 (Fig. 1D) as
shown previously for K2A [5]. A similar Ca2 elevation to
noradrenaline was seen if ATP (1 mM) was added prior to
noradrenaline (Fig. 1E). The Ca2 mobilising e¡ect of nor-
adrenaline was considerably attenuated in cells treated with
apyrase to remove extracellular purine nucleotides (Fig. 1F).
If ATP was added immediately prior to noradrenaline the
response to noradrenaline reappeared (Fig. 1G). The noradre-
naline-induced Ca2 response was reduced by 83%, 70% and
95% in K2A-, K2B- and K2C-expressing cells, respectively, by the
apyrase treatment (Fig. 2A).
The experiments described above indicate that the K2-adre-
noceptor-mediated Ca2 response requires the presence of pu-
rine nucleotides acting on the endogenous P2Y-receptors. To
test whether apyrase-sensitive adenine nucleotides were
present during the Ca2 measurements cells were labeled
with [3H]adenine and the cellular supernatants were assayed
for ATP/ADP chromatographically. Of the eluted ATP/ADP
fraction [24], 73 þ 2% (209451 þ 5453 cpm; average þ S.E.M.,
n = 3) was found intracellularly and 27 þ 2% (78923 þ 3692
cpm) extracellularly. Treatment with apyrase did not a¡ect
the intracellular activity (201820 þ 6161 cpm) but reduced
the extracellular activity to 1.6 þ 0.1% (3374 þ 167 cpm) of
the total radioactivity in this fraction. This suggests that a
large extracellular pool of one or both of these nucleotides
exists and that the endogenous P2Y-receptor ligands ADP
and/or ATP were indeed largely removed by the apyrase treat-
ment.
Addition of 200 WM suramin prior to noradrenaline (10
WM) or ATP (10 WM) caused a signi¢cant reduction of the
Ca2 mobilisation induced by either ligand (Fig. 2B).
To exclude the possibility that the e¡ects of apyrase and
suramin on the K2-adrenoceptor-mediated increase in intra-
cellular free Ca2 are due to a direct inhibition of the K2-
adrenoceptors, their e¡ect on the receptor-mediated inhibition
of cAMP accumulation was tested. Addition of forskolin to
CHO cells expressing K2C-adrenoceptor caused a 20-fold stim-
ulation of cAMP accumulation. Noradrenaline inhibited this
cAMP accumulation by 75 þ 6% (average þ S.E.M., n = 4).
Neither apyrase (68 þ 3% inhibition) nor suramin (80 þ 4%
inhibition) a¡ected this response.
If purine nucleotides present extracellularly indeed modify
the responses to the K2-adrenoceptors activation they should
be removable by constantly perfusing the cells. When nor-
adrenaline was applied to cells without perfusion it caused
a considerable Ca2 elevation seen as an increase in the
340/380 £uorescence ratio (Fig. 3A). Noradrenaline was, how-
ever, unable to induce Ca2 mobilisation in the perfused
cells unless it was applied soon after ATP (Fig. 3B) or
during constant perfusion with a low concentration of ATP
(1 WM).
4. Discussion
The sensitivity of the K2-adrenoceptor responses to apyrase,
suramin and perfusion indicates that the purinergic receptors
somehow potentiate K2-adrenoceptor-mediated Ca2 re-
sponses. As the Ca2 responses through K2-adrenoceptor are
dependent on Gi/Go and require LQ subunits [5] one likely
explanation is that these subunits and Kq (or some other G
protein K subunit) activated by the purinergic receptors coop-
erate in their stimulation of phospholipase C-L. Activation of
puri¢ed phospholipase C-L by LQ, unlike adenylyl cyclase [25],
does not have any apparent additional requirement for K sub-
units [11^13]. The situation may, however, be di¡erent in situ
in cells where the involvement of K subunits seems likely: a
co-activation of phospholipase C-L by K and LQ subunits has
been implicated in transfection and reconstitution experiments
[26,27]. Mobilisation of Ca2 by Go/Gi-coupled receptors has
in other studies been shown to be potentiated by activation of
Gq-coupled receptors [15^17]. It is therefore likely that the
pertussis toxin-sensitive Ca2 responses seen in several types
of cells upon stimulation of di¡erent Gi/Go-coupled receptors
[1] are due to a cooperative mechanism involving endoge-
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Fig. 3. E¡ect of perfusion of cells on noradrenaline-mediated in-
crease in intracellular free Ca2. Single cells were investigated using
image analysis. For these experiments the cells were grown on circu-
lar glass coverslips (diameter 22 mm) and loaded with 4 WM fura-2
acetoxymethyl ester at 37‡C in TBM for 20 min. In A, cells were
placed in a chamber with 1 ml of TBM and preincubated for
5 min. Noradrenaline and ATP were added by application directly
into the chamber. A volume of 0.35 ml was removed from the top
of the cells, mixed with the ligands and readded into the chamber.
The data are shown as an average of 16 cells ( þ S.D.). Four similar
experiments were performed with qualitatively similar results. In B,
the coverslips were placed in a perfusion chamber (0.2 ml volume)
and perfused with a rate of 0.5 ml per min for 5 min before appli-
cations were made. Where indicated, noradrenaline (10 WM) or ATP
(10 WM) was applied by perfusion. The data are shown as an aver-
age of 31 cells ( þ S.D.). Six similar experiments were performed
with qualitatively similar results. In C, conditions were as in B, ex-
cept that noradrenaline was applied before, during and after a per-
fusion with 1 WM ATP. The data are shown as an average of 16
cells ( þ S.D.). Five similar experiments were performed with qualita-
tively similar results.
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nously activated Gq-coupled receptors ^ possibly purinergic
receptors.
The presence of extracellular endogenous purine nucleotides
should thus be considered in studies describing signaling path-
ways in cells or tissues. It is of importance to recognise that
any basal, spontaneous or stimulated activity may already be
modi¢ed by the presence of these nucleotides.
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